<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141665573076250%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201904022%26RESULT%3d1%26SIGN%3d%252b0NIlh8Ap2FyaYB9Y8GlSAxqvtA%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904022&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904022&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904022&amp;v=MDEzMDJDVVI3cWZadVptRnlqblZMN0pQVFhNWmJHNEg5ak1xNDlIWm9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#28" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#29" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#32" data-title="1.2 治疗方法">1.2 治疗方法</a></li>
                                                <li><a href="#34" data-title="1.3 外周血心肌肌钙蛋白 T (cTnT) 、肌酸激酶同工酶 (CK-MB) 、IFN-γ、IL-4水平的测定">1.3 外周血心肌肌钙蛋白 T (cTnT) 、肌酸激酶同工酶 (CK-MB) 、IFN-γ、IL-......</a></li>
                                                <li><a href="#36" data-title="1.4 临床疗效">1.4 临床疗效</a></li>
                                                <li><a href="#38" data-title="1.5 统计学处理">1.5 统计学处理</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#41" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#42" data-title="2.1 两组治疗前、后血清IFN-γ和IL-4水平比较">2.1 两组治疗前、后血清IFN-γ和IL-4水平比较</a></li>
                                                <li><a href="#44" data-title="2.2 两组治疗前、后血清cTnT和CK-MB水平比较">2.2 两组治疗前、后血清cTnT和CK-MB水平比较</a></li>
                                                <li><a href="#46" data-title="2.3 两组疗效的比较">2.3 两组疗效的比较</a></li>
                                                <li><a href="#53" data-title="2.4 药物不良反应分析">2.4 药物不良反应分析</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#55" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#31" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组一般临床资料的比较&lt;/b&gt; (n=66) "><b>表</b>1 <b>两组一般临床资料的比较</b> (n=66) </a></li>
                                                <li><a href="#48" data-title="表2 两组血清IFN-γ和IL-4水平比较（&lt;image id=&quot;70&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904022_07000.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s，n=66) ">表2 两组血清IFN-γ和IL-4水平比较（<image id="70" type="formula" href="images/XXGK201904022_07000.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=66) </a></li>
                                                <li><a href="#50" data-title="表3 两组血清cTnT和CK-MB的水平比较（&lt;image id=&quot;71&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904022_07100.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s，n=66) ">表3 两组血清cTnT和CK-MB的水平比较（<image id="71" type="formula" href="images/XXGK201904022_07100.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=66) </a></li>
                                                <li><a href="#52" data-title="&lt;b&gt;表&lt;/b&gt;4 &lt;b&gt;两组临床疗效的比较&lt;/b&gt; (n=66) "><b>表</b>4 <b>两组临床疗效的比较</b> (n=66) </a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="张晓明, 李娟, 肖岳.葛根素联合左卡尼汀对心肌炎患儿氧化应激态及炎症因子的影响[J].现代医学, 2017, 45 (9) :1235-1240." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=TDYX201709002&amp;v=MjgxMzJGeWpuVkw3Sk1TblNkckc0SDliTXBvOUZab1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm0=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        张晓明, 李娟, 肖岳.葛根素联合左卡尼汀对心肌炎患儿氧化应激态及炎症因子的影响[J].现代医学, 2017, 45 (9) :1235-1240.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="Remels AHV, Derks WJA, Cillero-Pastor B, et al.NF-κB-mediated metabolic remodelling in the inflamed heart in acute viral myocarditis[J].Biochim Biophys Acta Mol Basis Dis, 2018, 1864 (8) :2579-2589." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES0CB63E915AE66A6734C21D4045551D8A&amp;v=MTEzNTRZd2ZMZVZNYkx1Q09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeExxNHdhaz1OaWZPZmJQTGJOZlAyb1pFWVpwNkNucEl5UkVRN2t4L1NRdm1yQg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        Remels AHV, Derks WJA, Cillero-Pastor B, et al.NF-κB-mediated metabolic remodelling in the inflamed heart in acute viral myocarditis[J].Biochim Biophys Acta Mol Basis Dis, 2018, 1864 (8) :2579-2589.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="顾坚, 鲍琼, 张仕超, 等.左卡尼汀对儿童病毒性心肌炎白介素-18及诱导型一氧化氮合酶的影响[J].儿科药学杂志, 2014, 20 (2) :5-7." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=EKYX201402002&amp;v=MzA0MDZxZlp1Wm1GeWpuVkw3SklDYlNkckc0SDlYTXJZOUZab1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        顾坚, 鲍琼, 张仕超, 等.左卡尼汀对儿童病毒性心肌炎白介素-18及诱导型一氧化氮合酶的影响[J].儿科药学杂志, 2014, 20 (2) :5-7.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="刘欢欢.环磷酰苷葡胺联合1, 6-二磷酸果糖治疗小儿病毒性心肌炎的临床观察[J].中国处方药, 2016, 14 (11) :34-35." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGCF201611023&amp;v=Mjk5MDI4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVkw3SlB5cklhTEc0SDlmTnJvOUhaNFFLREg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        刘欢欢.环磷酰苷葡胺联合1, 6-二磷酸果糖治疗小儿病毒性心肌炎的临床观察[J].中国处方药, 2016, 14 (11) :34-35.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="中华医学会儿科学分会心血管学组, 中华儿科杂志编辑委员会.病毒性心肌炎诊断标准 (修订草案) [J].中华儿科杂志, 2000, 38 (2) :75." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZHEK200002003&amp;v=MjIyMDl0SE1yWTlGWjRRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblZMN0pQeVhPWmJHNEg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        中华医学会儿科学分会心血管学组, 中华儿科杂志编辑委员会.病毒性心肌炎诊断标准 (修订草案) [J].中华儿科杂志, 2000, 38 (2) :75.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="李振平, 岳艳, 胡静平, 等.CVB3诱导的病毒性心肌炎小鼠模型中CD4～+T细胞亚群格局及其作用[J].现代免疫学, 2012, 32 (6) :463-467." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SHMY201206005&amp;v=MDAyNDZHNEg5UE1xWTlGWVlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblZMN0pOaVhHZDc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[6]</b>
                                        李振平, 岳艳, 胡静平, 等.CVB3诱导的病毒性心肌炎小鼠模型中CD4～+T细胞亚群格局及其作用[J].现代免疫学, 2012, 32 (6) :463-467.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title="Li L, Li L, Xiao L, et al.Progranulin ameliorates coxsackievirus-B3-induced viral myocarditis by downregulating Th1 and Th17 cells[J].Exp Cell Res, 2018, 367 (2) :241-250." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES5DC0FA9E45A608C3D7B939455A3A7C97&amp;v=MDk2MjlGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMcTR3YWs9TmlmT2ZiYk1iZEc2M29Zd1lPNStDbnd4dkJWbjdVMTBTM2JtcVJkRWVzT1ROck9ZQ09OdkZTaVdXcjdKSQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[7]</b>
                                        Li L, Li L, Xiao L, et al.Progranulin ameliorates coxsackievirus-B3-induced viral myocarditis by downregulating Th1 and Th17 cells[J].Exp Cell Res, 2018, 367 (2) :241-250.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="Liu L, Yue Y, Xiong S.NK-derived IFN-γ/IL-4 triggers the sexually disparate polarization of macrophages in CVB3-induced myocarditis[J].J Mol Cell Cardiol, 2014, 76 (1) :15-25." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=NK-derived IFN-gamma/IL-4 triggers the sexually disparate polarization of macrophages in CVB3-induced myocarditis">
                                        <b>[8]</b>
                                        Liu L, Yue Y, Xiong S.NK-derived IFN-γ/IL-4 triggers the sexually disparate polarization of macrophages in CVB3-induced myocarditis[J].J Mol Cell Cardiol, 2014, 76 (1) :15-25.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="李军红, 殷小成.黄芪注射液对病毒性心肌炎患儿Th1/Th2平衡的影响[J].现代医药卫生, 2016, 32 (10) :1451-1453." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XYWS201610005&amp;v=MjEzODM0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDdKUFRUY2ZiRzRIOWZOcjQ5RllZUUtESDg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        李军红, 殷小成.黄芪注射液对病毒性心肌炎患儿Th1/Th2平衡的影响[J].现代医药卫生, 2016, 32 (10) :1451-1453.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="李铭来.左卡尼汀在病毒性心肌炎急性期治疗中的应用研究[J].中西医结合心血管病电子杂志, 2018, 6 (1) :60-61." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZXJH201801043&amp;v=MDk1MDBESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDdKUHpYQlpyRzRIOW5Ncm85Qlo0UUs=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        李铭来.左卡尼汀在病毒性心肌炎急性期治疗中的应用研究[J].中西医结合心血管病电子杂志, 2018, 6 (1) :60-61.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="王波, 黄艳, 顾坚, 等.左卡尼汀对儿童病毒性心肌炎Th1/Th2平衡的影响[J].湖北科技学院学报 (医学版) , 2016, 30 (1) :46-47." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XNYB201601025&amp;v=MjA4ODJQU2JMRzRIOWZNcm85SFlZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDdKUFM=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        王波, 黄艳, 顾坚, 等.左卡尼汀对儿童病毒性心肌炎Th1/Th2平衡的影响[J].湖北科技学院学报 (医学版) , 2016, 30 (1) :46-47.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(04),478-481 DOI:10.3969/j.issn.1008-0074.2019.04.22            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>左卡尼汀联合环磷腺苷对病毒性心肌炎患者的疗效及对</b>IFN-γ<b>和</b>IL-4<b>水平的影响</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E8%B0%A2%E6%B7%91%E8%8A%B8&amp;code=37213163&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">谢淑芸</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E8%92%8B%E9%9D%96%E6%B3%A2&amp;code=06863854&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">蒋靖波</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E6%A1%82%E6%9E%97%E5%B8%82%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E5%BF%83%E8%A1%80%E7%AE%A1%E5%86%85%E7%A7%91&amp;code=0167035&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">桂林市人民医院心血管内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:观察左卡尼汀联合环磷腺苷对病毒性心肌炎 (VMC) 患者的疗效及对血清干扰素 (IFN) -γ和白介素 (IL) -4水平的影响。<b>方法</b>:2017年到2018年于我院治疗的VMC患者132例被随机均分为左卡尼汀组 (在常规治疗基础上接受左卡尼汀治疗) 和联合治疗组 (在左卡尼汀组基础上接受环磷腺苷治疗) , 两组均治疗2周。观察比较两组治疗前、后外周血血清IFN-γ、IL-4、心肌肌钙蛋白T (cTnT) 、肌酸激酶同工酶 (CK-MB) 水平, 临床疗效以及药物不良反应。<b>结果</b>:与治疗前比较, 治疗2周后两组血清IL-4水平均显著升高, 血清IFN-γ、cTnT和CK-MB水平均显著降低, <i>P</i>均=0.001;与左卡尼汀组比较, 联合治疗组血清IL-4水平[ (47.43±9.17) ng/ml比 (55.38±10.23) ng/ml]升高更显著, 血清IFN-γ[ (65.22±11.82) ng/ml比 (52.18±10.06) ng/ml]、cTnT[ (0.37±0.09) ng/ml比 (0.18±0.03) ng/ml]和CK-MB[ (28.56±5.34) U/L比 (16.22±3.47) U/L]水平降低更显著, <i>P</i>均=0.001。联合治疗组治疗总有效率显著高于左卡尼汀组 (92.4%比80.3%) , <i>P</i>=0.042。两组药物不良反应率无显著差异, <i>P</i>=0.784。<b>结论</b>:左卡尼汀联合环磷腺苷可以显著降低病毒性心肌炎患者外周血IFN-γ水平和升高IL-4水平, 调节Th1/Th2失衡, 疗效显著, 安全性好。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E8%82%8C%E7%82%8E&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心肌炎;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%B7%A6%E5%8D%A1%E5%B0%BC%E6%B1%80&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">左卡尼汀;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E7%8E%AFAMP&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">环AMP;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                            <b>作者简介：</b>
                                                        <span>
                                    *蒋靖波, E-mail:shu3ba@163.com;
                                </span>
                    </p>
                                    <p><b>收稿日期：</b>2018-09-03</p>

            </div>
                    <h1>Therapeutic effect of L-carnitine combined cyclic adenosine monophosphate and its influence on serum levels of IFN-γ and IL-4 in patients with viral myocarditis</h1>
                    <h2>
                    <span>XIE Shu-yun</span>
                    <span>JIANG Jing-bo</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, People′s Hospital of Guilin City</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>:To observe therapeutic effect of L-carnitine combined cyclic adenosine monophosphate and its influence on serum levels of IFN-γ and IL-4 in patients with viral myocarditis. <b>Methods</b>:A total of 132 VMC patients treated in our hospital from 2017 to 2018 were randomly and equally divided into L-carnitine group and combined treatment group (received cAMP based on L-carnitine group) , both groups were treated for two weeks. Peripheral serum levels of IFN-γ, IL-4, cardiac troponin T (cTnT) and creatine kinase isoenzyme MB (CK-MB) before and two weeks after treatment, therapeutic effect and incidence of adverse drug reactions were observed and compared between two groups. <b>Results</b>:Compared with before treatment, there was significant rise in serum IL-4 level, and significant reductions in serum levels of IFN-γ, cTnT and CK-MB in two groups after two-week treatment, <i>P</i>=0.001 all; compared with L-carnitine group, there was significant rise in serum IL-4 level [ (47.43±9.17) ng/ml vs. (55.38±10.23) ng/ml], and significant reductions in serum levels of IFN-γ[ (65.22±11.82) ng/ml vs. (52.18±10.06) ng/ml], cTnT[ (0.37±0.09) ng/ml vs. (0.18±0.03) ng/ml] and CK-MB [ (28.56± 5.34) U/L vs. (16.22±3.47) U/L] in combined treatment group, <i>P</i>=0.001 all. Total effective rate of combined treatment group was significantly higher than that of L-carnitine group (92.4% vs. 80.3%) , <i>P</i>=0.042. There was no significant difference in incidence rate of adverse drug reactions between two groups, <i>P</i>=0.784. <b>Conclusion</b>:L-carnitine combined cAMP can significantly reduce peripheral serum IFN-γ level and increase IL-4 level, regulate Th1/Th2 imbalance with significant therapeutic effect in VMC patients. And its safety is good.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Myocarditis&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Myocarditis;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=L-carnitine&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">L-carnitine;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Cyclic%20AMP&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Cyclic AMP;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                            <b>Author：</b>
                                                        <span>
                                    JIANG Jing-bo, E-mail: shu3ba@163.com;
                                </span>
                    </p>
                                    <p><b>Received：</b> 2018-09-03</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="27">病毒性心肌炎 (viral myocarditis, VMC) 是一种主要由肠道病毒和腺病毒感染引起的心血管系统常见疾病, 20%的心肌炎患者会发展为扩张型心肌病甚至充血性心衰<citation id="59" type="reference"><link href="5" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。近期的研究显示VMC导致的心肌损害并非由病毒直接引起, 病毒激发的过强免疫应答才是心肌破坏的主要原因, 免疫调节在VMC临床治疗中正逐渐受到重视<citation id="60" type="reference"><link href="7" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>。左卡尼汀是体内能量代谢中必需的天然物质, 主要分布于心肌、骨骼肌中, 临床研究发现左卡尼汀可以调节VMC患者的免疫应答反应<citation id="61" type="reference"><link href="9" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>, 环磷腺苷是核苷酸的衍生物, 在人体内广泛存在, 属于蛋白激酶致活剂, 具有重要的生理活性<citation id="62" type="reference"><link href="11" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>。本研究观察了左卡尼汀联合环磷腺苷对VMC患者干扰素 (IFN) -γ和白介素 (IL) -4水平的影响, 并分析其临床疗效。</p>
                </div>
                <h3 id="28" name="28" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="29" name="29">1.1 一般资料</h4>
                <div class="p1">
                    <p id="30">选择2017年1月至2018年7月于我院接受治疗的VMC患者132例。纳入对象:符合《病毒性心肌炎诊断标准 (2000年 修订草案) 》中的诊断标准<citation id="63" type="reference"><link href="13" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>, ≥18岁。排除对象:心、肝、肾、肺、脑重要脏器功能严重障碍患者, 伴发恶性肿瘤患者, 甲状腺异常或者伴发免疫异常性疾病患者, 最近一月曾服用激素或者免疫调节调节剂患者。使用随机数字表法, 132例患者被随机均分为左卡尼汀组和联合治疗组 (左卡尼汀+环磷腺苷) , 每组各66例。两组患者性别组成、年龄和病程临床资料间差异无统计学意义 (<i>P</i>均&gt;0.05) , 有可比性。见表1。</p>
                </div>
                <div class="area_img" id="31">
                    <p class="img_tit"><b>表</b>1 <b>两组一般临床资料的比较</b> (n=66)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="31" border="1"><tr><td><br />组别</td><td>男/女<br /> (例) </td><td>年龄<br /> (岁) </td><td>病程<br /> (d) </td></tr><tr><td><br />左卡尼汀组</td><td>35/31</td><td>32.26±6.42</td><td>3.64±0.57</td></tr><tr><td><br />联合治疗组</td><td>37/29</td><td>32.07±6.35</td><td>3.58±0.62</td></tr><tr><td><br /><i>t</i>/<i>χ</i><sup>2</sup></td><td>0.122</td><td>0.171</td><td>0.579</td></tr><tr><td><br /><i>P</i></td><td>0.727</td><td>0.865</td><td>0.564</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="32" name="32">1.2 治疗方法</h4>
                <div class="p1">
                    <p id="33">左卡尼汀组:患者卧床休息, 辅酶A100U+ATP100mg加入5%葡萄糖注射液250ml静滴, 进行基础治疗, 在常规治疗基础上给予左卡尼汀注射液 (哈尔滨松鹤制药有限公司, 批号:20161107、20171019) , 100mg /kg左卡尼汀静脉滴注, 1次/d, 疗程2周。联合治疗组在左卡尼汀组基础上联用环磷腺苷注射液 (石家庄四药有限公司, 批号:20161024/20170916) , 5%葡萄糖注射液稀释40mg环磷腺苷后静脉滴注, 1次/d, 疗程2周。</p>
                </div>
                <h4 class="anchor-tag" id="34" name="34">1.3 外周血心肌肌钙蛋白 T (cTnT) 、肌酸激酶同工酶 (CK-MB) 、IFN-γ、IL-4水平的测定</h4>
                <div class="p1">
                    <p id="35">治疗前和治疗2周后, 抽取所有患者不抗凝静脉血2ml, 1500g离心10min, 吸取上层血清, 交由检验科使用酶联免疫吸附法 (ELISA) 检测患者外周血cTnT、CK-MB、IFN-γ和IL-4水平, cTnT和CK-MB检测试剂盒购自上海酶联生物科技有限公司, IFN-γ和IL-4检测试剂盒购自南京建成生物工程研究所, 严格按照试剂盒说明书操作, 美国雅培AEROSET全自动生化分析仪检测各样品的水平。</p>
                </div>
                <h4 class="anchor-tag" id="36" name="36">1.4 临床疗效</h4>
                <div class="p1">
                    <p id="37">显效:临床症状、体征消失、心电图、心肌酶谱恢复正常;有效:临床症状、体征、心电图ST-T改善、心肌酶谱降低≥50%;无效:临床症状及体征无好转, 心电图ST-T未有变化、心肌酶谱无明显好转, 心律失常无明显改变, 或者病情进一步恶化。总有效率= (显效例数+有效例数) /总例数×100%。</p>
                </div>
                <h4 class="anchor-tag" id="38" name="38">1.5 统计学处理</h4>
                <div class="p1">
                    <p id="39">采用SPSS18.0统计软件进行统计学处理。计量资料以均数±标准差 (<image id="69" type="formula" href="images/XXGK201904022_06900.jpg" display="inline" placement="inline"><alt></alt></image>±s) 表示, 各组间比较采用独立<i>t</i>检验, 计数资料以百分率表示, 比较采用<i>χ</i><sup>2</sup>检验。<i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="41" name="41" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="42" name="42">2.1 两组治疗前、后血清IFN-γ和IL-4水平比较</h4>
                <div class="p1">
                    <p id="43">治疗前两组血清IFN-γ和IL-4水平差异均无显著性 (<i>P</i>均&gt;0.05) 。与治疗前比较, 治疗2周后两组IFN-γ水平显著降低, IL-4水平显著升高;与左卡尼汀组比较, 但联合治疗组治疗2周后血清IFN-γ水平显著降低, IL-4水平显著升高 (<i>P</i>均=0.001) 。见表2。</p>
                </div>
                <h4 class="anchor-tag" id="44" name="44">2.2 两组治疗前、后血清cTnT和CK-MB水平比较</h4>
                <div class="p1">
                    <p id="45">治疗前两组血清cTnT和CK-MB水平差异无显著性 (<i>P</i>均&gt;0.05) 。与治疗前比较, 治疗2周后两组cTnT和CK-MB水平均显著下降, 且联合治疗组较左卡尼汀组降低更显著 (<i>P</i>均=0.001) 。见表3。</p>
                </div>
                <h4 class="anchor-tag" id="46" name="46">2.3 两组疗效的比较</h4>
                <div class="p1">
                    <p id="47">联合治疗组总有效率为92.4% (61/66) , 显著高于左卡尼汀组的80.3% (53/66) (<i>χ</i><sup>2</sup>=4.117, <i>P</i>=0.042) 。见表4。</p>
                </div>
                <div class="area_img" id="48">
                                            <p class="img_tit">
                                                表2 两组血清IFN-γ和IL-4水平比较（<image id="70" type="formula" href="images/XXGK201904022_07000.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=66) 
                                                
                                                &nbsp;&nbsp;
                                                <a class="btn-zoomin" href="Detail/GetImg?filename=images/XXGK201904022_04800.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a>
                                                <a class="table downimg" data-tablename="Detail/GetImg?filename=images/XXGK201904022_04800.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">下载原表</a>
                                            </p>
                                    <a class="zoom-in" href="Detail/GetImg?filename=images/XXGK201904022_04800.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <img alt="表2 两组血清IFN-γ和IL-4水平比较（&#177;s，n=66)" src="Detail/GetImg?filename=images/XXGK201904022_04800.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                    </a>
                                <p class="img_note">注:IFN-γ:干扰素γ, IL-4:白介素4。与治疗前比较*<i>P</i>&lt;0.05, **<i>P</i>&lt;0.01;与左卡尼汀组比较△<i>P</i>&lt;0.05, △△<i>P</i>&lt;0.01。下表同。</p>

                </div>
                <div class="area_img" id="50">
                                            <p class="img_tit">
                                                表3 两组血清cTnT和CK-MB的水平比较（<image id="71" type="formula" href="images/XXGK201904022_07100.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=66) 
                                                
                                                &nbsp;&nbsp;
                                                <a class="btn-zoomin" href="Detail/GetImg?filename=images/XXGK201904022_05000.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a>
                                                <a class="table downimg" data-tablename="Detail/GetImg?filename=images/XXGK201904022_05000.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">下载原表</a>
                                            </p>
                                    <a class="zoom-in" href="Detail/GetImg?filename=images/XXGK201904022_05000.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <img alt="表3 两组血清cTnT和CK-MB的水平比较（&#177;s，n=66)" src="Detail/GetImg?filename=images/XXGK201904022_05000.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                    </a>
                                <p class="img_note">注:cTnT:心肌肌钙蛋白 T, CK-MB:肌酸激酶同工酶。</p>

                </div>
                <div class="area_img" id="52">
                    <p class="img_tit"><b>表</b>4 <b>两组临床疗效的比较</b> (n=66)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="52" border="1"><tr><td><br />组别</td><td>显效<br /><i>n</i> (%) </td><td>有效<br /><i>n</i> (%) </td><td>无效<br /><i>n</i> (%) </td><td>总有效率<br /><i>n</i> (%) </td></tr><tr><td><br />左卡尼汀组</td><td>39 (59.1) </td><td>22 (33.3) </td><td>5 (7.6) </td><td>61 (92.4) </td></tr><tr><td><br />联合治疗组</td><td>30 (45.5) </td><td>23 (34.9) </td><td>13 (19.7) </td><td>53 (80.3) </td></tr><tr><td><br /><i>χ</i><sup>2</sup>/<i>P</i></td><td></td><td></td><td></td><td>4.117/0.042</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="53" name="53">2.4 药物不良反应分析</h4>
                <div class="p1">
                    <p id="54">左卡尼汀组恶心2例、呕吐1例、头晕1例、头痛2例、注射部位疼痛1例, 不良反应发生率为10.6% (7/66) , 联合治疗组恶心1例、呕吐2例、头痛3例、腹痛1例、腹泻1例, 不良反应发生率为12.1% (8/66) , 两组不良反应发生率无显著性差异 (<i>χ</i><sup>2</sup>=0.075, <i>P</i>=0.784) 。</p>
                </div>
                <h3 id="55" name="55" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="56">虽然病毒性心肌炎 (VMC) 的致病机制尚未完全阐明, 但是炎症因子异常表达在VMC发生、发展中的主导地位已被大多数临床研究证实<citation id="64" type="reference"><link href="15" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>, Th1和Th2细胞是机体内一对免疫调节细胞, Th1分泌IFN-γ发挥致炎作用, Th2分泌IL-4拮抗Th1细胞和IFN-γ因子的致炎因作用, 二者维持机体的免疫平衡<citation id="68" type="reference"><link href="17" rel="bibliography" /><link href="19" rel="bibliography" /><sup>[<a class="sup">7</a>,<a class="sup">8</a>]</sup></citation>。已有研究观察到VMC中Th1/Th2网络失衡, 并且临床针对Th1/Th2失调的治疗可以获得显著的效果<citation id="65" type="reference"><link href="21" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>。左卡尼汀在机体内的主要功能是促进脂类代谢, 促进长链脂肪酸进入线粒体氧化分解, 为细胞提供能量, 再将分解后的短链脂酰基输出线粒体, 调节细胞脂质过氧化反应<citation id="66" type="reference"><link href="23" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>。王波等<citation id="67" type="reference"><link href="25" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>的研究发现左卡尼汀可以显著减低IFN-γ并升高IL-4水平, 调节Th1/Th2失调, 本研究结果与其一致。环磷腺苷作为激素的第2信使, 能调节细胞的多种功能活动, 通过增强心肌呼吸链氧化酶的活性, 改善心肌缺氧并增强心肌收缩。本研究显示左卡尼汀联用环磷腺苷后对VMC患者血清IFN-γ水平减低和IL-4水平升高作用均获得了显著加强, 说明了环磷腺苷可能增强了左卡尼汀对VMC患者Th1/Th2失衡的调节作用。</p>
                </div>
                <div class="p1">
                    <p id="57">cTnT和CK-MB是临床上监控心肌损伤的主要指标, 本研究观察到左卡尼汀联合环磷腺苷治疗联合治疗组2周疗程结束后血清cTnT和CK-MB水平显著低于左卡尼汀组, 说明前者更有利于患者心肌损伤的修复。临床疗效分析也显示了联合治疗组临床疗效显著高于左卡尼汀组。药物不良反应分析未见两组有显著性差异, 记录的临床不良反应患者均可以耐受, 不需特殊处理, 均在停药后恢复。</p>
                </div>
                <div class="p1">
                    <p id="58">综上所述, 本研究显示左卡尼汀联合环磷腺苷可以显著减低VMC患者外周血IFN-γ水平并升高IL-4水平, 调节Th1/Th2失衡, 疗效显著, 使用安全。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=TDYX201709002&amp;v=MDM4MzdMN0pNU25TZHJHNEg5Yk1wbzlGWm9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>张晓明, 李娟, 肖岳.葛根素联合左卡尼汀对心肌炎患儿氧化应激态及炎症因子的影响[J].现代医学, 2017, 45 (9) :1235-1240.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES0CB63E915AE66A6734C21D4045551D8A&amp;v=MjMzMDZ4L1NRdm1yQll3ZkxlVk1iTHVDT052RlNpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCckxVMDV0Qmh4THE0d2FrPU5pZk9mYlBMYk5mUDJvWkVZWnA2Q25wSXlSRVE3aw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>Remels AHV, Derks WJA, Cillero-Pastor B, et al.NF-κB-mediated metabolic remodelling in the inflamed heart in acute viral myocarditis[J].Biochim Biophys Acta Mol Basis Dis, 2018, 1864 (8) :2579-2589.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=EKYX201402002&amp;v=MTczODU3cWZadVptRnlqblZMN0pJQ2JTZHJHNEg5WE1yWTlGWm9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>顾坚, 鲍琼, 张仕超, 等.左卡尼汀对儿童病毒性心肌炎白介素-18及诱导型一氧化氮合酶的影响[J].儿科药学杂志, 2014, 20 (2) :5-7.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGCF201611023&amp;v=MjE2MDc0SDlmTnJvOUhaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVkw3SlB5cklhTEc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>刘欢欢.环磷酰苷葡胺联合1, 6-二磷酸果糖治疗小儿病毒性心肌炎的临床观察[J].中国处方药, 2016, 14 (11) :34-35.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZHEK200002003&amp;v=Mjc0MDRSN3FmWnVabUZ5am5WTDdKUHlYT1piRzRIdEhNclk5Rlo0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1U=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>中华医学会儿科学分会心血管学组, 中华儿科杂志编辑委员会.病毒性心肌炎诊断标准 (修订草案) [J].中华儿科杂志, 2000, 38 (2) :75.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SHMY201206005&amp;v=MDQ3MjRSN3FmWnVabUZ5am5WTDdKTmlYR2Q3RzRIOVBNcVk5RllZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1U=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[6]</b>李振平, 岳艳, 胡静平, 等.CVB3诱导的病毒性心肌炎小鼠模型中CD4～+T细胞亚群格局及其作用[J].现代免疫学, 2012, 32 (6) :463-467.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES5DC0FA9E45A608C3D7B939455A3A7C97&amp;v=MjAyNjBDbnd4dkJWbjdVMTBTM2JtcVJkRWVzT1ROck9ZQ09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeExxNHdhaz1OaWZPZmJiTWJkRzYzb1l3WU81Kw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[7]</b>Li L, Li L, Xiao L, et al.Progranulin ameliorates coxsackievirus-B3-induced viral myocarditis by downregulating Th1 and Th17 cells[J].Exp Cell Res, 2018, 367 (2) :241-250.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="http://scholar.cnki.net/result.aspx?q=NK-derived IFN-gamma/IL-4 triggers the sexually disparate polarization of macrophages in CVB3-induced myocarditis">

                                <b>[8]</b>Liu L, Yue Y, Xiong S.NK-derived IFN-γ/IL-4 triggers the sexually disparate polarization of macrophages in CVB3-induced myocarditis[J].J Mol Cell Cardiol, 2014, 76 (1) :15-25.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XYWS201610005&amp;v=MjQ5NzZZWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVkw3SlBUVGNmYkc0SDlmTnI0OUY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>李军红, 殷小成.黄芪注射液对病毒性心肌炎患儿Th1/Th2平衡的影响[J].现代医药卫生, 2016, 32 (10) :1451-1453.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZXJH201801043&amp;v=Mjc5NzNvOUJaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVkw3SlB6WEJackc0SDluTXI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>李铭来.左卡尼汀在病毒性心肌炎急性期治疗中的应用研究[J].中西医结合心血管病电子杂志, 2018, 6 (1) :60-61.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XNYB201601025&amp;v=Mjc2MjI4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVkw3SlBTUFNiTEc0SDlmTXJvOUhZWVFLREg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>王波, 黄艳, 顾坚, 等.左卡尼汀对儿童病毒性心肌炎Th1/Th2平衡的影响[J].湖北科技学院学报 (医学版) , 2016, 30 (1) :46-47.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201904022" />
        <input id="dpi" type="hidden" value="300" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904022&amp;v=MDEzMDJDVVI3cWZadVptRnlqblZMN0pQVFhNWmJHNEg5ak1xNDlIWm9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
